(a) Prevalence profiles derived from the PDD model (black line) and PDD-free model (red line) during 20 rounds of simulated annual MDA followed by 40 years with no intervention (the prevalence trajectory from the PDD-free model is shifted two months along the axis to improve clarity). In the presence of PDD, prevalence remains at 0% even after releasing MDA (a), while a lack of PDD allows the prevalence to rebound back to pre-MDA levels once MDA stops. (b) Mean prevalence-based BBR values of 100 model runs across 20 annual treatment rounds with error bars indicating standard deviation. (c) The prevalence-based elimination feasibility coefficient, ε, for the PDD model (black bars) and the PDD-free model (red bars) across each round of MDA. E...
The model introduced for the natural history of a progressive disease has four disease states which ...
<p>Compares the raw prevalence estimates to the final pooled prevalence output generated by DisMod-M...
a<p>Incidence of clinical episodes (episodes per person-year) in the absence of intervention at an E...
(a) Worm burden profiles derived from the PDD model (black line) and PDD-free model (red line) durin...
<p>MDA treatment coverage and impact on prevalence and DALYs 2006–2016 (data from [<a href="http://w...
BackgroundEffective mass drug administration (MDA) is the cornerstone in the elimination of lymphati...
The number of populations in each baseline prevalence group is shown on the x-axis. The x axis is th...
BackgroundEffective mass drug administration (MDA) is the cornerstone in the elimination of lymphati...
<p>Model outputs and observed infection data are shown for all the five PNG study villages. The obse...
a) prevalence of infection and disease prevalence change during re-emergence within the community, p...
Coverage increased with successive rounds of MDA, from a 3.5 percentage point increase for a second ...
<p>Panels indicate results for (a) a simple Macdonald MWB model without mating; (b) a MWB model with...
Background As the World Health Organization seeks to eliminate trachoma by 2020, countries are begin...
<p>When treatment efficacy increases, some of the decrease in disease prevalence is lost due to a de...
On the left is the proportion of individuals positive in each diagnostic state prior to MDA occurrin...
The model introduced for the natural history of a progressive disease has four disease states which ...
<p>Compares the raw prevalence estimates to the final pooled prevalence output generated by DisMod-M...
a<p>Incidence of clinical episodes (episodes per person-year) in the absence of intervention at an E...
(a) Worm burden profiles derived from the PDD model (black line) and PDD-free model (red line) durin...
<p>MDA treatment coverage and impact on prevalence and DALYs 2006–2016 (data from [<a href="http://w...
BackgroundEffective mass drug administration (MDA) is the cornerstone in the elimination of lymphati...
The number of populations in each baseline prevalence group is shown on the x-axis. The x axis is th...
BackgroundEffective mass drug administration (MDA) is the cornerstone in the elimination of lymphati...
<p>Model outputs and observed infection data are shown for all the five PNG study villages. The obse...
a) prevalence of infection and disease prevalence change during re-emergence within the community, p...
Coverage increased with successive rounds of MDA, from a 3.5 percentage point increase for a second ...
<p>Panels indicate results for (a) a simple Macdonald MWB model without mating; (b) a MWB model with...
Background As the World Health Organization seeks to eliminate trachoma by 2020, countries are begin...
<p>When treatment efficacy increases, some of the decrease in disease prevalence is lost due to a de...
On the left is the proportion of individuals positive in each diagnostic state prior to MDA occurrin...
The model introduced for the natural history of a progressive disease has four disease states which ...
<p>Compares the raw prevalence estimates to the final pooled prevalence output generated by DisMod-M...
a<p>Incidence of clinical episodes (episodes per person-year) in the absence of intervention at an E...